Page last updated: 2024-11-02

oxybutynin and Actinic Keratosis

oxybutynin has been researched along with Actinic Keratosis in 3 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Dattola, A1
Gutiérrez Garcìa-Rodrigo, C1
Tambone, S1
Garofalo, V1
Lappi, A1
De Luca, EV1
Peris, K1
Bianchi, L1
Campione, E1
Fargnoli, MC1
Braathen, LR1
Szeimies, RM1
Hauschild, A1
Ortland, C1
Moor, AC1
Stocker, M1
Surber, C1

Other Studies

3 other studies available for oxybutynin and Actinic Keratosis

ArticleYear
5-Aminolaevulinic acid patch photodynamic therapy for the treatment of actinic keratoses: preliminary results from an Italian study in the real-life setting.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2020, Volume: 155, Issue:5

    Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Italy; Keratosis, Actinic; Levulinic A

2020
Successful Daylight-PDT using a self-adhesive 5-aminolaevulinic acid patch.
    European journal of dermatology : EJD, 2018, Aug-01, Volume: 28, Issue:4

    Topics: Adhesives; Aged, 80 and over; Aminolevulinic Acid; Humans; Keratosis, Actinic; Male; Photochemothera

2018
Photodynamic therapy simplified: nonprepared, moderate-grade actinic keratosis lesions respond equally well to 5-aminolaevulinic acid patch photodynamic therapy as do mild lesions.
    The British journal of dermatology, 2015, Volume: 173, Issue:5

    Topics: Aminolevulinic Acid; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans

2015